Off the wire
• Foreign exchange rates in India  • Hong Kong stocks close up 2.08 pct  • More Chinese couples opt for second child  • Singapore's train services operator may face 50 mln SGD fine  • Chinese president welcomes Pakistan's entry into SCO  • Across China: Uygur pottery faces extinction due to lack of successors  • Interview: Industrial development becomes fertile ground for China-Mexico win-win cooperation  • China treasury bond futures close lower Friday  • Typhoon Chan-hom injures 20 in Okinawa, wreaks havoc on way to China  • Pacific nations agree to work closely in response to disasters  
You are here: 　 Home

New drug to treat leukemia successful in lab tests in Australia

Xinhua, July 10, 2015 Adjust font size:

Australian doctors are hoping a possible new cancer drug to treat an aggressive form of leukemia in children will be a success.

There are few treatments for children diagnosed with a relapsing type of leukaemia, a blood cancer, known as T-Cell acute lymphoblastic leukaemia (T-ALL).

A study from the Children's Cancer Institute in Sydney has involved testing the new drug on mice injected with cancer cells from children with T-ALL.

The drug is called PR-1042, and so far had been very successful in lab tests, but the next stage in its development would be getting a clinical trial approved, the Australian Broadcasting Corporation reported on Friday. Endi